| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 617613 | 63246 | ALPRAZOLAM NORMON 0,5 mg COMPRIMIDOS EFG | ALPRAZOLAM NORMON 0,5 mg COMPRIMIDOS EFG, 500 comprimidos | 0,5 mg | 5 | 500 | 10 | 500 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63246/63246_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63246/63246_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2000-07-14 | 1 | 1 | 1 | 2000-07-14 | 2000-07-14 | 1 | 2011-10-20 | Lista IV | View Edit Delete | |||||||||||
| 617662 | 63247 | ALPRAZOLAM NORMON 0,25 mg COMPRIMIDOS EFG | ALPRAZOLAM NORMON 0,25 mg COMPRIMIDOS EFG, 500 comprimidos | 0,25 mg | 5 | 500 | 10 | 500 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63247/63247_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63247/63247_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2000-07-14 | 1 | 1 | 1 | 2000-07-14 | 2000-07-14 | 1 | 2011-10-20 | Lista IV | View Edit Delete | |||||||||||
| 617696 | 63248 | ALPRAZOLAM NORMON 1 mg COMPRIMIDOS EFG | ALPRAZOLAM NORMON 1 mg COMPRIMIDOS EFG, 500 comprimidos | 1 mg | 5 | 500 | 10 | 500 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63248/63248_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63248/63248_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2000-07-14 | 1 | 1 | 1 | 2000-07-14 | 2000-07-14 | 1 | 2011-10-20 | Lista IV | View Edit Delete | |||||||||||
| 617803 | 63249 | ALPRAZOLAM NORMON 2 mg COMPRIMIDOS EFG | ALPRAZOLAM NORMON 2 mg COMPRIMIDOS EFG, 500 comprimidos | 2 mg | 5 | 500 | 10 | 500 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63249/63249_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63249/63249_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2000-07-14 | 1 | 1 | 1 | 2000-07-14 | 2000-07-14 | 1 | 2011-10-20 | Lista IV | View Edit Delete | |||||||||||
| 620781 | 63910 | TRAMADOL NORMON 50 MG CÁPSULAS DURAS EFG | TRAMADOL NORMON 50 MG CÁPSULAS DURAS EFG , 500 cápsulas | 50 mg | 5 | 500 | 43 | 500 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63910/63910_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63910/63910_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2001-05-21 | 1 | 1 | 1 | 2001-05-21 | 2001-05-21 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 621052 | 63129 | CAPTOPRIL / HIDROCLOROTIAZIDA NORMON 50 mg/25 mg COMPRIMIDOS EFG | CAPTOPRIL / HIDROCLOROTIAZIDA NORMON 50 mg/25 mg COMPRIMIDOS EFG , 500 comprimidos | 50 mg/25 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63129/63129_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63129/63129_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2000-05-29 | 1 | 1 | 1 | 2000-05-29 | 2000-05-29 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 621268 | 63159 | NORFLOXACINO NORMON 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | NORFLOXACINO NORMON 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 500 comprimidos | 400 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63159/63159_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63159/63159_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2000-06-06 | 1 | 1 | 1 | 2000-06-06 | 2000-06-06 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 607767 | 54626 | AMITRON 500 MG CÁPSULAS DURAS | AMITRON 500 MG CÁPSULAS DURAS, 100 cápsulas | 500 mg | 5 | 100 | 43 | 100 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/54626/54626_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/54626/54626_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1626 | LAPHYSAN S.A.U. | 1980-05-01 | 1 | 1 | 1 | 2013-10-28 | 2024-03-07 | 0 | 2025-11-10 | View Edit Delete | ||||||||||||
| 607122 | 83756 | ERELAN 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ERELAN 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 100 comprimidos | 400 mg | 5 | 100 | 10 | 100 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83756/83756_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83756/83756_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 28186 | MEDOCHEMIE IBERIA S.A. SUCURSAL EN ESPANA | 2019-01-11 | 1 | 1 | 1 | 2019-01-12 | 2019-01-11 | 0 | 2019-12-06 | View Edit Delete | ||||||||||||
| 612283 | 61717 | CARDYL 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 500 comprimidos | 20 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61717/61717_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61717/61717_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L.U. | 2000-11-14 | 1 | 1 | 1 | 2000-11-14 | 2001-01-09 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 615435 | 61718 | CARDYL 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 500 comprimidos | 40 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61718/61718_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61718/61718_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L.U. | 2000-11-14 | 1 | 1 | 1 | 2000-11-14 | 2001-03-28 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 621904 | 62655 | CARDURAN NEO 4 mg COMPRIMIDOS DE LIBERACION MODIFICADA | CARDURAN NEO 4 mg COMPRIMIDOS DE LIBERACION MODIFICADA, 500 comprimidos | 4 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62655/62655_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62655/62655_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L.U. | 1999-05-01 | 1 | 1 | 1 | 1999-05-01 | 2000-03-22 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 607639 | 3400935557506IP1 | CARDYL 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 500 comprimidos | 80 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/3400935557506IP1/3400935557506IP1_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 38087 | ECOFAR PRODUCTOS S.L. | 2023-03-15 | 1 | 1 | 1 | 2023-03-16 | 2023-03-15 | 1 | 2023-06-21 | View Edit Delete | ||||||||||||
| 618173 | 63269 | ENALAPRIL BELMAC 20 mg COMPRIMIDOS EFG | ENALAPRIL BELMAC 20 mg COMPRIMIDOS EFG, 500 comprimidos | 20 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63269/63269_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63269/63269_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2000-07-21 | 1 | 1 | 1 | 2000-07-21 | 2000-07-21 | 1 | 2017-03-06 | View Edit Delete | ||||||||||||
| 619338 | 63568 | ENALAPRIL BELMAC 2,5 mg COMPRIMIDOS | ENALAPRIL BELMAC 2,5 mg COMPRIMIDOS, 500 comprimidos | 2,5 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63568/63568_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63568/63568_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2001-01-10 | 1 | 1 | 1 | 2001-01-10 | 2001-01-10 | 1 | 2013-02-11 | View Edit Delete | ||||||||||||
| 619346 | 63567 | ENALAPRIL BELMAC 10 mg COMPRIMIDOS | ENALAPRIL BELMAC 10 mg COMPRIMIDOS, 500 comprimidos | 10 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63567/63567_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63567/63567_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2001-01-10 | 1 | 1 | 1 | 2001-01-10 | 2001-01-10 | 1 | 2013-02-11 | View Edit Delete | ||||||||||||
| 607611 | 88467 | QUIROCROM 20 MG/ML + 0,70 ML/ML SOLUCION CUTANEA | QUIROCROM 20 MG/ML + 0,70 ML/ML SOLUCION CUTANEA, 15 frascos | 20 mg/ml + 0,70 mg/ml | 6 | 3750 | 26 | 15 frascos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88467/88467_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88467/88467_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2513 | LABORATORIOS SALVAT S.A. | 2022-12-28 | 1 | 1 | 1 | 2022-12-29 | 2022-12-28 | 1 | 2023-01-31 | View Edit Delete | ||||||||||||
| 607612 | 88469 | CRISTALMINA PLUS 20 MG/ML + 0,70 ML/ML SOLUCIÓN PARA PULVERIZACIÓN CUTÁNEA | CRISTALMINA PLUS 20 MG/ML + 0,70 ML/ML SOLUCIÓN PARA PULVERIZACIÓN CUTÁNEA, 30 frascos de 125 ml | 20 mg/ml + 0,7 mg/ml | 6 | 3750 | 26 | 30 frascos de 125 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88469/88469_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88469/88469_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2513 | LABORATORIOS SALVAT S.A. | 2022-12-30 | 1 | 1 | 1 | 2022-12-31 | 2022-12-30 | 0 | 2023-01-31 | View Edit Delete | ||||||||||||
| 607089 | 73900 | FLUCONAZOL KABI 2 MG/ML SOLUCION PARA PERFUSION EFG | FLUCONAZOL KABI 2 MG/ML SOLUCION PARA PERFUSION EFG, 20 frascos de 50 ml | 2 mg/ml inyectable 50 ml | 6 | 20 | 48 | 20 frascos de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73900/73900_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73900/73900_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2013-11-08 | 1 | 1 | 1 | 2013-11-08 | 2018-10-17 | 1 | 2019-07-23 | View Edit Delete | ||||||||||||
| 607090 | 73900 | FLUCONAZOL KABI 2 MG/ML SOLUCION PARA PERFUSION EFG | FLUCONAZOL KABI 2 MG/ML SOLUCION PARA PERFUSION EFG, 20 frascos de 100 ml | 200 mg | 6 | 20 | 48 | 20 frascos de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73900/73900_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73900/73900_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2013-11-08 | 1 | 1 | 1 | 2013-11-08 | 2018-10-17 | 1 | 2019-10-22 | View Edit Delete |
Page 31 of 1036, showing 20 records out of 20709 total, starting on record 601, ending on 620